RxDoctor Payments Data

Norma Norden

Medical Oncology · Mobile, ALNPI 1790098770

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,241 of the $1,907 with a category attached, or 65.1%. 24 manufacturers reported payments, led by Novartis at 46.6% of the total. Reporting peaked in 2021 at $812 and has fallen 87.1% since, to $105 in 2024. That places this record below the midpoint for medical oncology clinicians in AL, where the typical reported total is $5,924.

$1,907in general payments, 2019–2025

Across 80 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$888
  • Amgen$124
  • Merck$116
  • Daiichi Sankyo Inc.$110
  • Bristol Myers Squibb$97
  • Lilly USA, LLC$84
  • plus $488 from 18 others

What the payments were for

  • Food & beverage$1,24165%
  • Education$342%
  • Other$63233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,907 in reported general payments places this provider in the 25th percentile of 30 medical oncology providers in Alabama.

See all medical oncology providers in Alabama

Other medical oncology in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →